Lauxera Capital Partners invests in GenePlanet as BlackPeak Capital partially exits stake

PUBT · 2d ago
Lauxera Capital Partners invests in GenePlanet as BlackPeak Capital partially exits stake
  • GenePlanet, a European genomics and laboratory diagnostics platform, secured a strategic investment from healthtech investor Lauxera Capital Partners.
  • BlackPeak Capital partially exited its stake, crystallizing gains while retaining a minority holding as GenePlanet targets further global expansion.
  • GenePlanet provides genetic testing and next-generation sequencing services, operating a lab hub in Zagreb within a broader pan-European platform.
  • The company expanded from 24 countries in 2023 to more than 50 markets, supported by four bolt-on acquisitions and new proprietary tests.
  • Fresh capital is earmarked for product expansion into oncology and rare-disease panels, with a push into Western Europe and the US.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Black Peak Capital Partners AD published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.